113 related articles for article (PubMed ID: 11302799)
21. [Anti-HIV activities of HIV-1 reverse transcriptase inhibitor racemic 11-demethyl-calanolide A].
Peng ZG; Chen HS; Wang L; Liu G
Yao Xue Xue Bao; 2008 May; 43(5):456-60. PubMed ID: 18717330
[TBL] [Abstract][Full Text] [Related]
22. Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication.
Buckheit RW; Russell JD; Xu ZQ; Flavin M
Antivir Chem Chemother; 2000 Sep; 11(5):321-7. PubMed ID: 11142630
[TBL] [Abstract][Full Text] [Related]
23. Pyranocoumarins from tropical species of the genus Calophyllum: a chemotaxonomic study of extracts in the National Cancer Institute collection.
McKee TC; Covington CD; Fuller RW; Bokesch HR; Young S; Cardellina II JH; Kadushin MR; Soejarto DD; Stevens PF; Cragg GM; Boyd MR
J Nat Prod; 1998 Oct; 61(10):1252-6. PubMed ID: 9784162
[TBL] [Abstract][Full Text] [Related]
24. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
Vaughan D; Speed J; Medve R; Andrews JS
Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of single oral doses of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor, in healthy volunteers.
Holdich T; Shiveley L; Sawyer J
Clin Drug Investig; 2006; 26(5):279-86. PubMed ID: 17163261
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected Ugandans.
Nanzigu S; Eriksen J; Makumbi F; Lanke S; Mahindi M; Kiguba R; Beck O; Ma Q; Morse GD; Gustafsson LL; Waako P
HIV Med; 2012 Apr; 13(4):193-201. PubMed ID: 22107359
[TBL] [Abstract][Full Text] [Related]
27. Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.
Boyer PL; Currens MJ; McMahon JB; Boyd MR; Hughes SH
J Virol; 1993 Apr; 67(4):2412-20. PubMed ID: 7680393
[TBL] [Abstract][Full Text] [Related]
28. Safety, tolerability and pharmacokinetics of rilpivirine following administration of a long-acting formulation in healthy volunteers.
Verloes R; Deleu S; Niemeijer N; Crauwels H; Meyvisch P; Williams P
HIV Med; 2015 Sep; 16(8):477-84. PubMed ID: 25988676
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
30. Calanolides, the naturally occurring anti-HIV agents.
Xu ZQ; Flavin MT; Jenta TR
Curr Opin Drug Discov Devel; 2000 Mar; 3(2):155-66. PubMed ID: 19649847
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects.
Christopher R; Covington P; Davenport M; Fleck P; Mekki QA; Wann ER; Karim A
Clin Ther; 2008 Mar; 30(3):513-27. PubMed ID: 18405789
[TBL] [Abstract][Full Text] [Related]
33. Effects of hepatic impairment on the steady-state pharmacokinetics of etravirine 200 mg BID: an open-label, multiple-dose, controlled Phase I study in adults.
Schöller-Gyüre M; Kakuda TN; De Smedt G; Woodfall B; Berckmans C; Peeters M; Hoetelmans RM
Clin Ther; 2010 Feb; 32(2):328-37. PubMed ID: 20206790
[TBL] [Abstract][Full Text] [Related]
34. Randomized, placebo-controlled single-ascending-dose study to evaluate the safety, tolerability and pharmacokinetics of the HIV nucleoside reverse transcriptase inhibitor, BMS-986001, in healthy subjects.
Urata Y; Paintsil E; Cheng YC; Matsuda T; Sevinsky H; Hawthorne D; Bertz R; Hanna GJ; Grasela D; Hwang C
J Clin Pharmacol; 2014 Jun; 54(6):657-64. PubMed ID: 24374821
[TBL] [Abstract][Full Text] [Related]
35. Single- and multiple-dose pharmacokinetics of a hydrocodone bitartrate extended-release tablet formulated with abuse-deterrence technology in healthy, naltrexone-blocked volunteers.
Darwish M; Yang R; Tracewell W; Robertson P; Bond M
Clin Ther; 2015 Feb; 37(2):390-401. PubMed ID: 25542074
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity modifications of the HIV-1 inhibitors (+)-calanolide A and (-)-calanolide B.
Galinis DL; Fuller RW; McKee TC; Cardellina JH; Gulakowski RJ; McMahon JB; Boyd MR
J Med Chem; 1996 Oct; 39(22):4507-10. PubMed ID: 8893846
[TBL] [Abstract][Full Text] [Related]
37. Safety, tolerability, and pharmacokinetics of single oral doses of BCH-10652 in healthy adult males.
Smith PF; Forrest A; Ballow CH; Martin DE; Proulx L
Antimicrob Agents Chemother; 2000 Oct; 44(10):2816-23. PubMed ID: 10991865
[TBL] [Abstract][Full Text] [Related]
38. Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers.
Martin DE; Blum R; Wilton J; Doto J; Galbraith H; Burgess GL; Smith PC; Ballow C
Antimicrob Agents Chemother; 2007 Sep; 51(9):3063-6. PubMed ID: 17576843
[TBL] [Abstract][Full Text] [Related]
39. New pyranocoumarins isolated from Calophyllum lanigerum and Calophyllum teysmannii.
McKee TC; Fuller RW; Covington CD; Cardellina JH; Gulakowski RJ; Krepps BL; McMahon JB; Boyd MR
J Nat Prod; 1996 Aug; 59(8):754-8. PubMed ID: 8792623
[TBL] [Abstract][Full Text] [Related]
40. Tolerability and dose proportional pharmacokinetics of pasireotide administered as a single dose or two divided doses in healthy male volunteers: a single-center, open-label, ascending-dose study.
Petersenn S; Hu K; Maldonado M; Zhang Y; Lasher J; Bouillaud E; Wang Y; Mann K; Unger N
Clin Ther; 2012 Mar; 34(3):677-88. PubMed ID: 22364824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
